Clinical Trial: Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Open-label, Phase II Study of KPS-0373 in Patients With SCD

Brief Summary: To evaluate the efficacy, safety and pharmacokinetics profile of KPS-0373 in patients with SCD

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome: Scale for the assessment and rating of ataxia (SARA), ADL(Flow-FIM), Patient Improvement Impression [ Time Frame: 12 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: March 16, 2009
Date Started:
Date Completion:
Last Updated: February 1, 2010
Last Verified: February 2010